{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T03:53:02Z","timestamp":1771041182398,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-02948-8","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T07:02:42Z","timestamp":1718434962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cost-effectiveness analysis of laboratory monitoring in newly diagnosed telogen effluvium patients"],"prefix":"10.1007","volume":"316","author":[{"given":"Rhiannon C.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaya L.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajjad","family":"Abedian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"2948_CR1","doi-asserted-by":"publisher","unstructured":"Miller RC, Abedian S, Lipner SR (2023) Shedding low yield testing for telogen effluvium: A cross-sectional study of 16,381 laboratory results from newly diagnosed patients. J Am Acad Dermatol. May 26:S0190-9622(23)00984-2. https:\/\/doi.org\/10.1016\/j.jaad.2023.05.045. Epub ahead of print. PMID: 37245837","DOI":"10.1016\/j.jaad.2023.05.045"},{"key":"2948_CR2","unstructured":"Centers for Medicare & Medicaid Services (2022) Clinical laboratory fee schedule, CY 2021 Q1 Release. http:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/index.html. Accessed April 18"},{"issue":"15","key":"2948_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1001\/jama.2019.13978","volume":"322","author":"WH Shrank","year":"2019","unstructured":"Shrank WH, Rogstad TL, Parekh N (2019) Waste in the US Health Care System: estimated costs and potential for savings. JAMA 322(15):1501\u20131509. https:\/\/doi.org\/10.1001\/jama.2019.13978","journal-title":"JAMA"},{"key":"2948_CR4","unstructured":"Choosing Wisely (2022) Choosing Wisely. [online] Available at: <https:\/\/www.choosingwisely.org\/ [Accessed 28 April 2022]"},{"issue":"3","key":"2948_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijwd.2018.01.003","volume":"4","author":"AJ Chiaravalloti","year":"2018","unstructured":"Chiaravalloti AJ, Jinna S, Kerr PE, Whalen J, Grant-Kels JM (2018) A deep look into thin melanomas: what\u2019s new for the clinician and the impact on the patient. Int J Women\u2019s Dermatology 4(3):119\u2013121. https:\/\/doi.org\/10.1016\/j.ijwd.2018.01.003","journal-title":"Int J Women\u2019s Dermatology"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-02948-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-02948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:31:56Z","timestamp":1725913916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-02948-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-02948-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"13 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of Weill Cornell Medicine (record #: 19-11021049).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Dr. Rhiannon Miller, Ms. Kaya Curtis, and Mr. Sajjad Abedian have no conflicts of interest. Dr. Lipner has served as a consultant for Ortho-Dermatologics, Moberg Pharmaceuticals, Eli Lilly, and BelleTorus Corporation.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"388"}}